UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies

Einsele, H; Briones, J; Ciceri, F; García Cadenas, I; Falkenburg, F; Bolaños, N; Heemskerk, HMM; ... van de Loosdrecht, AA; + view all (2021) The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies. Hemasphere , 5 (10) , Article e642. 10.1097/HS9.0000000000000642. Green open access

[thumbnail of The_EHA_Research_Roadmap__Immune_based_Therapies.pdf]
Preview
Text
The_EHA_Research_Roadmap__Immune_based_Therapies.pdf - Published Version

Download (414kB) | Preview

Abstract

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European Hematology Research. the 11 EHA Research Roadmap sections include normal hematopoiesis; malignant lymphoid diseases; malignant myeloid diseases; anemias and related diseases; platelet disorders; blood coagulation and hemostatic disorders; transfusion medicine; infections in hematology; hematopoietic stem cell transplantation; CAR-T and Other cell-based immune therapies; and gene therapy.

Type: Article
Title: The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1097/HS9.0000000000000642
Publisher version: http://dx.doi.org/10.1097/HS9.0000000000000642
Language: English
Additional information: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
URI: https://discovery.ucl.ac.uk/id/eprint/10135808
Downloads since deposit
41Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item